Paper · 189490

Efficiency of transformation of lymphocytes by Epstein-Barr virus.

Henderson E and 3 others. Virology, 1977. Cited by 190 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Efficiency of transformation of lymphocytes by Epstein-Barr virus. Papers, record 189490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/189490

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Efficiency of transformation of lymphocytes by Epstein-Barr virus.; PubMed
Journal: Virology; PubMed
Year: 1977; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/189490/; PubMed
DOI: https://doi.org/10.1016/0042-6822(77)90292-6; PubMed
The journal: https://conductscience.org/library/journal-index/0110674; PubMed
Citations, by iCite: 190; iCite
Relative citation ratio, by iCite: 3.89; iCite
Revised in PubMed: 2019-07-14; PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Henderson E	E
2	Miller G	G
3	Robinson J	J
4	Heston L	L

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Herpesvirus 4, Human	Major topic
Lymphocyte Activation	Major topic
Animals
Callitrichinae
Cell Count
Cell Line
DNA
Fetal Blood
Haplorhini
Humans
Lectins
Lipopolysaccharides
Lymphocytes
Polysaccharides, Bacterial
T-Lymphocytes

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by82

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 190 citations.

PMID	Title	Journal	Year	In Papers	Source
41,105,850	Withaferin A inhibits EBV-driven lymphomagenesis through multiple mechanisms, including EBNA1 degradation.	Blood	2026	https://conductscience.org/library/papers/41105850	PubMed
40,549,805	Kaposi sarcoma-associated herpesvirus cooperates with Epstein-Barr virus to co-transform a small set of human B cells oncogenically.	PLoS Pathog	2025	https://conductscience.org/library/papers/40549805	PubMed
39,599,857	How Epstein Barr Virus Causes Lymphomas.	Viruses	2024	https://conductscience.org/library/papers/39599857	PubMed
38,027,600	Momordica anti-HIV protein MAP30 abrogates the Epstein-Barr virus nuclear antigen 1 dependent functions in host cells.	Heliyon	2023	https://conductscience.org/library/papers/38027600	PubMed
36,070,681	Methionine metabolism controls the B cell EBV epigenome and viral latency.	Cell Metab	2022	https://conductscience.org/library/papers/36070681	PubMed
34,768,838	Nanotechnology Frontiers in γ-Herpesviruses Treatments.	Int J Mol Sci	2021	https://conductscience.org/library/papers/34768838	PubMed
34,158,342	Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells.	Mol Cancer Ther	2021	https://conductscience.org/library/papers/34158342	PubMed
31,257,153	Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.	Cell Metab	2019	https://conductscience.org/library/papers/31257153	PubMed
30,662,441	Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?	Front Immunol	2018	https://conductscience.org/library/papers/30662441	PubMed
29,617,291	Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma.	Cancers (Basel)	2018	https://conductscience.org/library/papers/29617291	PubMed

1 to 10 of 82

See all 82 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/189490

GET https://conductscience.org/api/papers/v1/189490/cited_by?page=2

API reference For AI assistants